Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can lipitor decrease yoga staminaAre there any alternatives to lipitor for nutrient absorptionDoes lipitor affect flexibility in yoga practiceHow does lipitor impact other meds blood pressure lowering abilityHow does acyclovir resistance develop
Keytruda, a drug used for the treatment of various types of cancers, was authorized by the U.S. Food and Drug Administration (FDA) in 2014. According to the FDA's announcement, Keytruda (pembrolizumab) received accelerated approval for the treatment of advanced melanoma in September 2014 [3]. Additionally, the drug was granted approval for adjuvant treatment of non-small cell lung cancer in October 2019 [1]. Further information about Keytruda's approval and patents can be found in the Drug Patent Watch report [2]. Sources: [1] <https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-keytruda-pembrolizumab-adjuvant-treatment-non-small-cell-lung> [2] <https://www.drugpatentwatch.com/p/biologics/tradename/KEYTRUDA> [3] <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679831/>
Follow-up: In what year did Keytruda receive FDA authorization? Can you recall the year Keytruda was FDA-approved? What's the approval year for Keytruda, as per FDA?
DrugPatentWatch - Make Better Decisions © thinkBiotech LLC 2004 - 2024. All rights reserved.